http://pozn1-diabenot.blogs-narod.ru/?r=http%3A%2F%2Fb.diabenot.ru%2F%3Fref%3Dcpa%26zevs%3D2345%26click_id%3DDACzC_DhCvBNXBY.
OBJECTIVE We have developed a new antihyperglycemic agent (teglicar) through the selective and reversible inhibition of the liver isoform of carnitine palmitoyl-transferase 1 (L-CPT1).
You may look: